Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
13 studies found for:    appendiceal cancer | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Gastrointestinal Microbiome Study of Appendiceal Cancer
Conditions: Pseudomyxoma Peritonei;   Appendiceal Neoplasm;   Cancer, Appendiceal
Interventions: Other: Bio-specimen collection;   Other: Questionnaire
2 Recruiting Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
Conditions: Colorectal Cancer;   Appendix Cancer;   Peritoneal Carcinomatosis
Intervention: Drug: Oxaliplatin
3 Recruiting Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
Condition: Gastrointestinal Neoplasms
Intervention: Behavioral: Questionnaire
4 Recruiting ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Conditions: Appendix Cancer;   Colorectal Cancer
Interventions: Procedure: Cytoreductive Surgery;   Drug: HIPEC with Mitomycin-C;   Drug: EPIC with FUDR and Leucovorin
5 Recruiting Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Condition: Cancer
Intervention: Drug: systemic chemotherapy
6 Recruiting Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Conditions: Pseudomyxoma Peritonei;   Appendiceal Neoplasms
Intervention: Drug: PrevPac (Prevacid, Amoxicillin, Clarithromycin)
7 Recruiting The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
Condition: Appendicitis
Interventions: Drug: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin;   Procedure: Appendectomy
8 Recruiting Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery
Condition: Solid Organ Cancers
Interventions: Biological: GL-ONC1;   Biological: Eculizumab
9 Recruiting Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
Condition: Carcinoma
Interventions: Drug: Intraperitoneal Oxaliplatin;   Drug: Bevacizumab;   Drug: Capecitabine
10 Recruiting Cobimetinib and Atezolizumab in Advanced Rare Tumors
Conditions: Malignant Neoplasms of Digestive Organs;   Melanoma and Other Malignant Neoplasms of Skin;   Appendiceal Adenocarcinoma;   Cutaneous Squamous Cell Carcinoma;   Small Bowel Adenocarcinoma
Interventions: Drug: Cobimetinib;   Drug: Atezolizumab
11 Not yet recruiting Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
Conditions: Cancer, Appendiceal;   ColoRectal Cancer
Interventions: Drug: Mitomycin c;   Drug: Melphalan
12 Recruiting Community-based Neuroendocrine Tumor (NET) Research Study
Condition: Gastroenteropancreatic Neuroendocrine Tumors
Intervention:
13 Recruiting Atezolizumab and Bevacizumab in Rare Solid Tumors
Conditions: Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs
Interventions: Drug: Atezolizumab;   Drug: Bevacizumab;   Behavioral: Phone Call

Study has passed its completion date and status has not been verified in more than two years.